Myocardial ischemia in women: lessons from the NHLBI WISE study

Area of Science:

• Cardiology
• Women's Health
• Medical Research

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality for women globally.
• Women experience higher CVD mortality rates than men, with recent data showing over 421,000 deaths in the US.
• While CHD mortality has declined in men, younger women (<55 years) show an increasing trend.

Purpose of the Study:

• To review the pathophysiology and mechanisms of ischemic heart disease (IHD) specifically in women.
• To highlight sex-specific differences in myocardial ischemia prevalence, symptoms, and outcomes.
• To examine traditional and novel risk factors, diagnostic approaches, and therapeutic strategies for IHD in women, referencing the WISE study.

Main Methods:

• Literature review focusing on sex-specific aspects of IHD in women.
• Analysis of data and findings from the Women's Ischemia Syndrome Evaluation (WISE) study.
• Examination of epidemiological trends, clinical presentations, and pathophysiological mechanisms.

Main Results:

• Significant sex-based disparities exist in the prevalence, symptoms, and underlying mechanisms of myocardial ischemia.
• Risk factors for IHD in women may differ from those in men, necessitating tailored risk assessment.
• Diagnostic and therapeutic strategies require adaptation to address the unique aspects of IHD in women.

Conclusions:

• Understanding the sex-specific nature of IHD is crucial for improving outcomes in women.
• Further research and tailored clinical approaches are needed to address the disproportionate burden of CVD in women.
• The WISE study provides valuable insights into managing IHD in women effectively.